RESUMO
OBJECTIVE: The purpose of our study was to describe the MRI findings in the posterior cruciate ligament (PCL) analogous to mucoid degeneration in the anterior cruciate ligament (ACL); to correlate MRI findings in the PCL with ligamentous stability; to differentiate the PCL tram-track appearance from the appearance of PCL tears; and to emphasize the coexistence of PCL and ACL mucoid degeneration, cruciate ganglia, and meniscal cysts. CONCLUSION: The tram-track PCL appearance commonly coexists with ACL mucoid degeneration; ganglia; and, less frequently, meniscal cysts. Both PCL tears and MRI findings suggestive of PCL mucoid degeneration show ligament thickening and increased PCL signal intensity. Tram-track PCLs are usually asymptomatic and typically have no ligamentous instability.
Assuntos
Lesões do Ligamento Cruzado Anterior , Traumatismos do Joelho/diagnóstico , Imageamento por Ressonância Magnética/métodos , Ligamento Cruzado Posterior/lesões , Adolescente , Adulto , Idoso , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos RetrospectivosRESUMO
BACKGROUND: Excessive energy intake and obesity lead to the metabolic syndrome (MetS). Dietary saturated fatty acids (SFAs) may be particularly detrimental on insulin sensitivity (SI) and on other components of the MetS. OBJECTIVE: This study determined the relative efficacy of reducing dietary SFA, by isoenergetic alteration of the quality and quantity of dietary fat, on risk factors associated with MetS. DESIGN: A free-living, single-blinded dietary intervention study. SUBJECTS AND METHODS: MetS subjects (n = 417) from eight European countries completed the randomized dietary intervention study with four isoenergetic diets distinct in fat quantity and quality: high-SFA; high-monounsaturated fatty acids and two low-fat, high-complex carbohydrate (LFHCC) diets, supplemented with long chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs) (1.2 g per day) or placebo for 12 weeks. SI estimated from an intravenous glucose tolerance test (IVGTT) was the primary outcome measure. Lipid and inflammatory markers associated with MetS were also determined. RESULTS: In weight-stable subjects, reducing dietary SFA intake had no effect on SI, total and low-density lipoprotein cholesterol concentration, inflammation or blood pressure in the entire cohort. The LFHCC n-3 PUFA diet reduced plasma triacylglycerol (TAG) and non-esterified fatty acid concentrations (P < 0.01), particularly in men. CONCLUSION: There was no effect of reducing SFA on SI in weight-stable obese MetS subjects. LC n-3 PUFA supplementation, in association with a low-fat diet, improved TAG-related MetS risk profiles.
Assuntos
Gorduras na Dieta/administração & dosagem , Comportamento Alimentar/fisiologia , Resistência à Insulina/fisiologia , Síndrome Metabólica/prevenção & controle , Obesidade/dietoterapia , Dieta com Restrição de Gorduras/métodos , Gorduras na Dieta/metabolismo , Ingestão de Energia/fisiologia , Europa (Continente) , Ácidos Graxos/administração & dosagem , Ácidos Graxos/efeitos adversos , Ácidos Graxos Insaturados/administração & dosagem , Feminino , Glicerol/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Obesidade/metabolismo , Fatores de RiscoRESUMO
BACKGROUND AND AIMS: The Metabolic Syndrome (MetS) is associated with increased cardiovascular risk. Circulating microparticles (MP) are involved in the pathogenesis of atherothrombotic disorders and are raised in individual with CVD. We measured their level and cellular origin in subjects with MetS and analyzed their associations with 1/anthropometric and biological parameters of MetS, 2/inflammation and oxidative stress markers. METHODS AND RESULTS: Eighty-eight subjects with the MetS according to the NCEP-ATPIII definition were enrolled in a bicentric study and compared to 27 healthy controls. AnnexinV-positive MP (TMP), MP derived from platelets (PMP), erythrocytes (ErMP), endothelial cells (EMP), leukocytes (LMP) and granulocytes (PNMP) were determined by flow cytometry. MetS subjects had significantly higher counts/µl of TMP (730.6±49.7 vs 352.8±35.6), PMP (416.0±43.8 vs 250.5±23.5), ErMP (243.8±22.1 vs 73.6±19.6) and EMP (7.8±0.8 vs 4.0±1.0) compared with controls. LMP and PNMP were not statistically different between groups. Multivariate analysis demonstrated that each criterion for the MetS influenced the number of TMP. Waist girth was a significant determinant of PMP and EMP level and blood pressure was correlated with EMP level. Glycemia positively correlated with PMP level whereas dyslipidemia influenced EMP and ErMP levels. Interestingly, the oxidative stress markers, plasma glutathione peroxydase and urinary 8-iso-prostaglandin F(2) α, independently influenced TMP and PMP levels whereas inflammatory markers did not, irrespective of MP type. CONCLUSION: Increased levels of TMP, PMP, ErMP and EMP are associated with individual metabolic abnormalities of MetS and oxidative stress. Whether MP assessment may represent a marker for risk stratification or a target for pharmacological intervention deserves further investigation.
Assuntos
Plaquetas/patologia , Micropartículas Derivadas de Células/metabolismo , Células Endoteliais/patologia , Eritrócitos/metabolismo , Síndrome Metabólica/patologia , Estresse Oxidativo , Adulto , Idoso , Biomarcadores/sangue , Plaquetas/metabolismo , Estudos de Casos e Controles , Micropartículas Derivadas de Células/patologia , Células Endoteliais/metabolismo , Feminino , Citometria de Fluxo , Humanos , Interleucina-6/sangue , Modelos Lineares , Masculino , Síndrome Metabólica/sangue , Pessoa de Meia-Idade , Fator de Necrose Tumoral alfa/sangue , Molécula 1 de Adesão de Célula Vascular/sangueRESUMO
To investigate the effect of ethanol on carbohydrate homeostasis in circumstances in which food and ethanol are usually ingested, ethanol was administered hourly in the afternoon prior to the ingestion of a glucose load at 5:00 p.m. in a group of normal subjects and in mild diabetics. In both groups the blood glucose levels following the glucose load were 30-80 mg/100 ml lower and the early insulin secretory response (15-45 min) was 35 percent-40 percent higher after ethanol ingestion. In contrast, ethanol intake had no effect on the glucagon response to glucose ingestion; These data suggest that ethanol enhances glucose-stimulated insulin secretion. The dampened blood glucose rise observed with ethanol may be related to the augmented insulin response or to decreased gastrointestinal absorption of glucose. In mild diabetic patients, moderate intake of ethanol is without acute deleterious effects on carbohydrate homeostasis and may in some instances improve the blood glucose response to ingested carbohydrate.
Assuntos
Diabetes Mellitus/metabolismo , Etanol/farmacologia , Glucose/metabolismo , Insulina/metabolismo , Adulto , Glicemia/metabolismo , Dieta , Carboidratos da Dieta/administração & dosagem , Etanol/sangue , Feminino , Glucagon/metabolismo , Teste de Tolerância a Glucose , Humanos , Insulina/sangue , Secreção de Insulina , Absorção Intestinal/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Pâncreas/metabolismo , Fatores de TempoRESUMO
A total of eight anticholinergic drugs (aprophen, atropine, azaprophen, benactyzine, biperiden, procyclidine, scopolamine, trihexyphenidyl) were tested in parallel with diazepam for the ability to terminate seizure activity induced by the nerve agent soman. Guinea pigs, implanted with electrodes to record cortical electroencephalographic (EEG) activity, were pretreated with pyridostigmine Br (0.026 mg/kg, i.m.) and 30 min later challenged with 2 x LD50 soman (56 microg/kg, s.c.) followed 1 min later by treatment with atropine SO4 (2 mg/kg, i.m.) and pralidoxime chloride (2-PAM Cl; 25 mg/kg, i.m.). All guinea pigs developed sustained seizure activity following this treatment. Dose-effect curves were determined for the ability of each drug to terminate seizure activity when anticonvulsant treatment was given either 5 or 40 min after seizure onset. Body weight gain and recovery of behavioral performance of a previously trained one-way avoidance task were measured after exposure. With the exception of atropine, all anticholinergic drugs were effective at lower doses than diazepam in terminating seizures when given 5 min after seizure onset; benactyzine, procyclidine and aprophen terminated seizures most rapidly while scopolamine, trihexyphenidyl, biperiden, and diazepam were significantly slower. When given 40 min after seizure onset, diazepam was the most potent compound tested, followed by scopolamine, benactyzine and biperiden; atropine was not effective when tested 40 min after seizure onset. For diazepam, the time to terminate the seizure was the same whether it was given at the 5- or 40-min delay. In contrast, most anticholinergics were significantly slower in terminating seizure activity when
Assuntos
Anticonvulsivantes/farmacologia , Substâncias para a Guerra Química/toxicidade , Antagonistas Colinérgicos/farmacologia , Convulsivantes/antagonistas & inibidores , Convulsivantes/toxicidade , Diazepam/farmacologia , Soman/antagonistas & inibidores , Soman/toxicidade , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Eletroencefalografia/efeitos dos fármacos , Cobaias , Masculino , Sistema Nervoso/patologia , Análise de Sobrevida , Fatores de TempoRESUMO
Isoflurane (1-chloro-2,2,2-trifluoroethyl difluoromethyl ether) is a potent general anesthetic agent that is highly adaptable to use in small laboratory animal species. Respiratory delivery is easily accomplished in these animals, even during restraint in a stereotaxic apparatus. The ease of administration, high predictability of action, and ability to finely control the depth of anesthesia make isoflurane anesthesia far superior to regimes involving injectable anesthetics. The wide margin of safety of isoflurane is a key indicator of the superiority of this product to all other anesthetic agents. The initial cost associated with the delivery system is a drawback, but the reliability and safety factors outweigh the hardware costs.
Assuntos
Anestesia por Inalação/veterinária , Anestésicos Inalatórios/administração & dosagem , Isoflurano/administração & dosagem , Técnicas Estereotáxicas/veterinária , Procedimentos Cirúrgicos Operatórios/veterinária , Animais , Desenho de Equipamento/economia , Desenho de Equipamento/veterinária , Cobaias , Masculino , Reprodutibilidade dos Testes , Técnicas Estereotáxicas/instrumentação , Procedimentos Cirúrgicos Operatórios/economia , Procedimentos Cirúrgicos Operatórios/métodosRESUMO
Whole-grain diets are linked to reduced risk of several chronic diseases (heart disease, cancer, diabetes, metabolic syndrome) and all-cause mortality. There is increasing evidence that these benefits are associated with the gut microbiota and that release of fibre-related phenolic metabolites in the gut is a contributing factor. Additional sources of these metabolites include fruits and vegetables, but the evidence for their protective effects is less well established. With respect to the availability of bound phytophenols, ready-to-eat cereals are compared with soft fruits (considered rich in antioxidants) and other commonly consumed fruits and vegetables. The results demonstrated that when compared with an equivalent serving of fruits or vegetables, a recommended portion of whole-grain cereals deliver substantially higher amounts of bound phytophenols, which are available for metabolism in the colon. The increased amount of these phenolic metabolites may, in part, explain the evidence for the protective effects of whole-grain cereals.
Assuntos
Grão Comestível/química , Fast Foods/análise , Frutas/química , Fenol/química , Extratos Vegetais/química , Verduras/química , Antioxidantes/química , Antioxidantes/metabolismo , Fibras na Dieta/análise , Fibras na Dieta/metabolismo , Grão Comestível/metabolismo , Frutas/metabolismo , Humanos , Fenol/metabolismo , Extratos Vegetais/metabolismo , Verduras/metabolismoRESUMO
A 49-year-old Laotian woman presented with apathetic hyperthyroidism and suppurative thyroiditis from Salmonella cholerae-suis occurring in a multinodular gland with a large right-sided mass. Apathetic hyperthyroidism in this age group is uncommon and Salmonella thyroiditis has been infrequently described. Surgical removal of the mass which had effectively concentrated radioactive iodine cured the hyperthyroidism and permitted the remaining suppressed normal tissue to regain function. Pathologic evaluation of the functioning mass demonstrated nearly total replacement of normal thyroid tissue by follicular carcinoma. No clear evidence of metastatic disease was present. Thyrotoxicosis from follicular carcinoma of the thyroid not resulting from metastases has not been previously described.
Assuntos
Adenocarcinoma/complicações , Hipertireoidismo/complicações , Infecções por Salmonella/complicações , Neoplasias da Glândula Tireoide/complicações , Tireoidite/complicações , Adenocarcinoma/patologia , Adenocarcinoma/cirurgia , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/cirurgiaRESUMO
This study reports on the pharmacokinetics of the elimination of the metabolites of three toxic organophosphorus compounds (soman, sarin and GF). Urine, blood and lung tissue were collected from rats dosed subcutaneously at 75 micrograms kg-1. Urinary excretion of the metabolite was the major elimination route for these three compounds. The major differences among them were primarily the extent and rate of excretion. The hydrolyzed form, alkylmethylphosphonic acid, was the single major metabolite formed and excreted in urine by a non-saturable mechanism. Nearly total recoveries of the given doses for sarin and GF in metabolite form were obtained from the urine. The terminal elimination half-lives in urine were 3.7 +/- 0.1 and 9.9 +/- 0.8 h for sarin and GF, respectively. Soman metabolite showed a biphasic elimination curve with terminal half-lives of 18.5 +/- 2.7 and 3.6 +/- 2.2 h. Soman was excreted at a slower rate with a recovery of only 62%. Lung was the major organ of accumulation for soman. In blood the toxic agents were concentrated more in red blood cells than in plasma. The acid metabolites can serve as a better chemical marker for monitoring organophosphorus exposure in humans via their higher concentration and longer half-life in urine than the parent compounds.
Assuntos
Compostos Organofosforados/metabolismo , Compostos Organofosforados/farmacocinética , Animais , Monitoramento Ambiental/métodos , Masculino , Ratos , Ratos Endogâmicos , Sarina/metabolismo , Sarina/farmacocinética , Soman/metabolismo , Soman/farmacocinéticaRESUMO
This study evaluated the ability of six benzodiazepines to stop seizures produced by exposure to the nerve agent soman. Guinea pigs, previously prepared with electrodes to record electroencephalographic (EEG) activity, were pretreated with pyridostigmine (0.026 mg/kg, i.m.) 30 min before challenge with soman (56 microg/kg, s.c.) and then treated 1 min after soman exposure with atropine (2.0 mg/kg, i.m.) and pralidoxime chloride (2-PAM Cl; 25 mg/kg, i.m.). All animals developed seizures following this treatment. Benzodiazepines (avizafone, clonazepam, diazepam, loprazolam, lorazepam, and midazolam) were given i.m. 5 or 40 min after seizure onset. All benzodiazepines were effective in stopping soman-induced seizures, but there were marked differences between drugs in the rapidity of seizure control. The 50% effective dose (ED50) values and latencies for anticonvulsant effect for a given benzodiazepine were the same at the two times of treatment delay. Midazolam was the most potent and rapidly acting compound at both treatment times. Since rapid seizure control minimizes the chance of brain damage, use of midazolam as an anticonvulsant may lead to improved clinical outcome in the treatment of nerve agent seizures.
Assuntos
Anticonvulsivantes/farmacologia , Benzodiazepinas/farmacologia , Substâncias para a Guerra Química/toxicidade , Convulsivantes/toxicidade , Convulsões/induzido quimicamente , Convulsões/prevenção & controle , Soman/antagonistas & inibidores , Soman/toxicidade , Animais , Relação Dose-Resposta a Droga , Eletroencefalografia/efeitos dos fármacos , Cobaias , Masculino , Fatores de TempoRESUMO
The major metabolites and breakdown products of some toxic organophosphonates are their respective alkymethylphosphonic acids. These acids ionize at physiological pH and are not amenable to gas chromatographic analysis in their underivatized forms. Their detection in biological samples has been difficult because of their presence at only trace levels. Existing analytical methods were developed mainly for measuring these phosphonic acids in environmental samples and at higher concentrations. In this study, we devised a gas chromatographic/mass spectrometric method to provide confirmation and quantification of the organophosphonic acids of soman (GD), sarin (GB) and GF in blood and urine. This report describes the various derivatization conditions that we have studied and demonstrates the characteristic mass spectra by different ionization techniques.